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Quantitative systems pharmacology (QSP) models aim to mechanistically describe 22 disease progression and predict the effects of existing therapies or novel 23 compounds on disease biomarkers or outcomes. For most drug development 24 applications, it is important to predict not only the mean response to the 25 intervention but also the inter-patient variability. In addition, given the complexity 26 of QSP models and the sparsity of relevant human data, the parameters of QSP 27 models are often not well-determined. One approach to overcome these limitations 28 is to develop Virtual Populations (VPops), which allow for the exploration of 29 parametric uncertainty and reproduce the variability in response to perturbation. 30
Here we evaluate approaches to improve the efficiency of generating VPops. We 31 aimed to generate these populations without sacrificing diversity of the Virtual 32
Patients' (VPs) pathophysiologies and phenotypes. To do this, we used our 33 previously published approach (Allen, Rieger et al. 2016 ) together with two 34 established algorithms (genetic algorithm and Metropolis-Hastings) as well as 35 developing a novel approach, which we call "nested simulated annealing." Each 36 method improved our previously-published algorithm in at least one aspect. For 37 example, all of the methods tested required significantly fewer plausible patients 38 (PP), the precursors to VPs, to create a reasonable VPop, but we found there may be 39 tradeoffs in terms of parametric and phenotypic diversity of the VPs. However, the 40 improved methodologies introduced here may be appropriate in many applications. 41 42
Introduction
43
Physiologically-based mathematical models are often used to describe and predict 44 the response of a patient to an existing therapy or novel agent. These models, 45 frequently referred to as quantitative systems pharmacology (QSP) models, are used 46 to simulate clinical trials in drug development (Musante, Ramanujan et al. 2017 ). In 47 these applications, it is important that they not only capture the mean patient 48 response to treatment but also interpatient variability and how that variability may 49 evolve over time. In addition, due to the novel nature of many therapies; the 50 complexity of human physiology; and generally limited human data, QSP models are 51 rarely fully determined by data. One approach to these challenges is to develop 52 alternate parameter sets to capture the variability in the real clinical trial population 53 and sample as much uncertainty in the model parameters as possible (Gadkar, 54 Budha Previously, we published an algorithm for the generation and selection of these 57 alternative value sets (Allen, Rieger et al. 2016 ). The flow of the algorithm was to 58 use simulated annealing to generate as large a population of "plausible virtual 59
patients" as was practical. Simulated annealing was used with a given cost 60 functional that optimized solutions to be biologically feasible. These plausible 61 patients, and as a collection plausible population, were termed plausible since each 62 generated parameter set simulated a patient that was physiologically reasonable, 63
and could be in a clinical trial, but there was not yet any selection for how likely it 64 was for that patient to have been in a particular clinical trial. We then used our 65 novel selection technique to choose those patients from the plausible population 66 that most resembled a desired clinical population. These selected patients were then 67 termed virtual patients (VPs), and as a collection they were called a virtual 68 population (Vpop). 69
Since the original algorithm created a plausible population that was naïve to the 70 targeted virtual population distribution, significant computational effort was 71 expended in generating spurious plausible patients outside of the target 72 distribution. Here we propose additional algorithms to improve the generation of 73 the plausible population for more efficient generation of the virtual population. The 74 common extension of our previous approach in each of the tested algorithms is to 75 use information about the target distribution in generating the plausible population. 76
We explored this idea in three ways: (1) a novel method we have termed "nested 77 simulated annealing" (NSA), which repeatedly targets a simulated annealing method 78 to fill portions of the output-space at the correct frequency to approximate the 79 target distribution; (2) a population-based global optimization approach, in this 80 case MATLAB's genetic algorithm (GA); and lastly, (3) an important-sampling 81 technique, which for this application we chose the Metropolis-Hastings (MH) 82 method ( Figure 1 ). We also re-simulated the original method, which uses simulated 83 annealing, for direct comparison to the three new approaches. 84
Methods
85
The focus of this paper is the evaluation of three approaches for the generation of 86 virtual populations that match empirical distributions of clinical cohorts or 87
populations. This section is organized to describe these three methods (NSA-nested  88  simulated annealing, GA-modified genetic algorithm, and MH-modified Metropolis-89 Hastings), and how to apply them to generate virtual patients (VPs). This is followed 90 by a description of how the results were analyzed, including a novel metric for 91 assessing the uniqueness of a collection of parameter sets. 92
Mathematical Model and Data
93
Following our previous approach, we test our proposed methods using a publicly- 
Nested Simulated Annealing
106
The nested simulated annealing (NSA) approach is a novel method we developed to 107 use information about the target data distribution in the process of generating the 108 plausible population. Previously we optimized the steady-state solutions, * , to 109 within biologically reasonable ranges rather than to a specific point using the 110 following cost functional 111 We use the following equation for the contour of an ellipsoid that will encompass 134 the data: 135
where is a 3 × 1 vector representing a point in the log-scaled observable space, 137
and are maximum likelihood estimation of the mean and covariance matrix of the 138 multivariate normal distribution, and ! controls the size of the ellipsoid. By letting 139 be the data point furthest from the mean in (2), we can explicitly calculate the 140 minimum value for ! that allows the data to be encompassed by the ellipsoid. 141
First consider only one ellipsoid region. Then the modified cost functional is 142 
with the !! ellipsoid centered at the mean and defined as ! = { : − 155
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where ( ) is the multivariate normal distribution, and = 1 … . We find an 160 approximate solution, ! , to this integral, by using a Monte Carlo approach. 161
Equivalently, 162
For this method, we are going to populate each ellipsoid such that the proportion of 166 plausible patients within each ellipsoid matches the target distribution. We 167 therefore need to calculate how many plausible patients are required for each 168 ellipsoid, given a desired total number of plausible patients. Define ! as the 169 proportion of the total plausible population within the !! ellipsoid. Then, since we 170 assume the observables are approximately uniformly distributed throughout each 171 ellipsoid, we want to solve a system of R equations for each ! obtained by solving 172
173 for = 1, … , . Where ! is the volume of the !! ellipse. We define ! = 0. Note that 174
where is the dimension of the multi-dimensional distribution. Then, 175 equation (7) can be re-written as 176 With the ellipses defined we can generate the plausible population by randomly 183 generating a parameter set in the ranges we defined from a uniform distribution. 184
Then, for a plausible population of size , for = 1 to , we optimize from our 185 initial parameter estimate to our final plausible patient via minimizing 186 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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where is given by equation (1) 
where ( ) is the likelihood of a given log-scaled observable value given by 207
This cost functional can be interpreted as forcing all state variables to be within 209 plausible biological bounds and additionally assessing a penalty as the log-scaled 210 observables deviate from . 211
In implementing this algorithm, we start with an initial population of individuals, 212
where each individual is created by random selection of parameter values from a 213 uniform distribution with biologically-reasonable bounds. As the algorithm 214 progresses, children are created for each generation; those with a cost functional 215 value < 0 become plausible patients. Since many plausible patients are 216 created each generation, there is no way to specify the exact number of plausible 217 patients generated. Thus we must preset the minimum number of plausible patients 218 desired, but in practice we tended to generate slightly more than sought (see 219
Supplementary Code). Once the plausible population is created, we follow the 220 remaining steps in Allen et al. and use rejection sampling to determine the virtual 221 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Modified Metropolis-Hastings
223
First, recall the original Metropolis-Hasting (MH) algorithm to approximate a 224 desired distribution, for a review see for example (Robert 2015) . Let ( ) be our 225 desired target multivariate probability distribution for the vector (in this case is 226 a parameter set of the model). The MH algorithm generates a sequence of , such 227 that the distribution of this sequence, { , … , } converges to as → ∞. Let 228
, be some symmetric proposal distribution, which is interpreted as 229 generating a proposed value from , when the process is at value p. Then the 230
original Metropolis Hastings algorithm is as follows: 231 1. Generate an initial vector , set = 1. 232 2. Generate a proposed vector * ~ ! , * . 233 3. Calculate the probability * is accepted, = min 1,
5. Repeat steps 2 to 4 for = 1, … , to collect { , … , } as a sampling from 236 the target distribution. 237
This MH algorithm approximates the target distribution by randomly sampling 238 from it. At first glance, this approach appears immediately applicable to the problem 239 at hand and will generate a plausible population that will converge to the virtual 240 population as → ∞. However, this algorithm requires modification because we do 241 not know ( ) ; i.e., we do not know how the parameters sets should be 242 distributed such that the model, when simulated using those parameters, matches 243 the data. 244
We rewrite our target distribution as ( ), where is the observable outcomes 245 generated by the model , using a parameter set (which in this case is in the log-246 space, so = log ( )). Then our algorithm becomes 247 1. Generate an initial vector , set = 1. 248 2. Generate a proposed vector * ~ ! , * , write 249
3. Calculate the probability * is accepted, = min 1,
5. Repeat steps 2 to 4 for = 1, … , to collect { , … , } as a sampling from 254 the target distribution. 255
In the canonical version of the MH algorithm is independent of the proposal 256 distribution because it is symmetric and cancels out of the equation. In the 257 modified version above, ! is unknown and, in fact, is unlikely to be symmetric. In 258 order to proceed we assume that ! is approximately symmetric 259
* , so that we can calculate as above. Because of this 260 approximation it is still necessary, following our previously published algorithm, to 261 apply acceptance-rejection sampling to determine the virtual population from the 262 plausible population. 263
Assessing Similarity Between Virtual Patients
264
It is desirable to examine the parameter space in the virtual population to ensure 265 heterogeneity of the virtual patients (while still reproducing available data). In our 266 method this was previously ensured by generating VPs independently and from 267 different initial parameter estimates. However, this is not necessarily the case for 268 the GA and MH methods. 269
To assess the diversity of a virtual population we devised a test metric ( , ) 270 which scores how similar two VPs are. By bootstrapping sampling pairs of VPs from 271 a given virtual population, we built up a distribution for and could compare the 272 resultant cumulative density function (CDF) for each method. The test metric is 273 simply the normalized dot-product of and after they are scaled and shifted: 274
where is a diagonal matrix such that = − . Hence, diag( ! − ) uses 276 the defined upper and lower bound for each parameter (the elements of and 277 respectively), to scale each parameter in to be between 0 and 1. To ensure that 278 ∈ [−1,1] we further subtract ½ from each element. This means that, in principle, 279 can be orientated in any direction in -dimensional space (where is the 280 number of parameters). This also means that if the elements of are sampled 281 uniformly between the upper and lower bounds that, by symmetry, the expected 282 value of the distribution should be zero (i.e., the CDF crosses 0.5 at = 0). This is 283 the optimal parameter set in terms of diversity, but may not be achievable given the 284 constraints applied to the model. Conversely, if we generate virtual populations 285 from very similar parameter sets then the distribution will be right-shifted towards 286 =1. 287
Assessing Goodness of Fit
288
The goodness of fit (GoF) to the empirical target distribution was assessed by using 289 the Kolmogorov-Smirnov statistic for each marginal distribution in one dimension: 290 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Comparison of algorithms for efficiency of yield
317
For each algorithm, we targeted generation of between 100 and 10,000 total PPs; 318 those PPs were then converted into VPs through the acceptance/rejection 319 algorithm. The GoF of the resulting VPop was calculated as discussed in Methods. By 320 comparing the GoF achieved for the VPops with varying PPs (Figure 2 ) we find that 321 as the number of PPsà10,000+, all of the algorithms generated essentially 322 indistinguishable GoFs for the final VPop (albeit with different VPs in each VPop). 323
However, the three new algorithms were more efficient than the original SA method, 324 especially when the number of PPs < 1,000. In fact, VPops generated with as few as 325 100 PPs could have similar fits to the observable data as the SA method with 500+ 326
PPs. 327 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
Comparison of algorithms for computational cost
328
Even if an algorithm can generate the same GoF through far fewer PPs than the 329 original SA algorithm, this does not necessarily mean the process was 330 computationally more efficient. We further compared each method based on the 331 clock time (evaluated via MATLAB's tic/toc functions) required to generate a VPop 332 from 10,000 plausible patients (Figure 3 ). While the NSA method was arguably 333 superior based on yield, this algorithm required approximately the same amount of 334 time to execute as the SA method. Based on time, the MH and GA were the fastest 335 algorithms and the SA remains among the least efficient. Therefore, we need to ensure that as we introduce new algorithms, we do not trade 345 parametric diversity for computational gains. We measured the diversity of the 346
VPops generated by each algorithm by uniformly sampling pairs of VPs and 347 calculating the dot product between each set of parameters (see Methods). As a 348 reference point, we included a set of uniformly, randomly generated model 349 parameters (Figure 4 ). The closer each algorithm's final VP parameter distribution 350 is to the random reference, the more diverse we considered the set of VPs in the 351
Vpop. For this criterion, the SA method was found to have the most diversity, closely 352 followed by NSA and MH. The GA method showed distinct rightward shifts in its 353 distribution, indicating that fewer independent parameter sets were identified in 354 the generation of the VPops. Supplementary figures show the violin plot for each 355 method for both the PPs and VPs ( Figures S2, S4 , S6, and S8). 356
Convergence of the algorithms to the data
357
In contrast to the original SA method, each of the methods tested use information 358 about the desired population distribution and thus requires fewer plausible patients 359 to achieve an acceptable fit for the VPop (Figure 2 ). To evaluate if the final selection 360 step was still required as part of the algorithm workflow, we compared the GoF for 361 each of the methods before and after the acceptance/rejection step, starting with 362 ~10,000 PPs in each case ( Figure 5 ). As expected, the largest improvement in VPop 363 fit from the PPs to VPs was for the SA method; however, all of the methods showed 364 at least a 3-fold improvement in GoF through the final selection step. The NSA 365 method showed the best initial fit for its plausible patients to the NHANES data, 366 reasonably reproducing both the 1-dimensional and 2-dimensional histograms 367 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/196089 doi: bioRxiv preprint first posted online  before the selection step ( Figure S3A-F Therefore, with this perspective, we can use these models in a hypothesis-375 generation/testing mode to explore how these knowledge gaps translate to 376 uncertainties in clinical outcomes and clinical trial design. In our opinion, the most 377 thorough and robust way of doing this is by generating the most diverse virtual 378 populations given the available data. 379
Exploring the parameter space of under-determined quantitative systems 380 pharmacology models remains a challenge but it is essential for safety and efficacy 381 predictions for novel compounds. Here we presented three methods for generating 382 diverse parameter sets in a QSP model. While this exercise is by no means an 383 exhaustive exploration of global optimization techniques, each algorithm improved 384 at least one of the testing metrics compared to our previously published SA method. 385
The seemingly simple question of which method is "the best" cannot be definitively 386 answered here but it is important to be aware of the pros and cons for each and 387 potential steps to improve performance. 388
We have previously discussed the advantages and disadvantages of using the SA 389 method for this application (Allen, Rieger et al. 2016 ). In comparison to other 390 methods tested it was the slowest (or tied with NSA), required the most plausible 391 patients for a quality fit but on the plus side it also generated the most (or tied with 392 NSA) diverse virtual population with the fewest imposed correlations. The ease of 393 implementation was also an advantage for SA. As implemented, the algorithm 394 required no prior knowledge of the final virtual population distribution and there 395 was a minimal set of tuning parameters required, most of which were default 396 MATLAB options (i.e., no arbitrary decision about number of ellipses, number of 397 generations). As such, the algorithm remains relevant as a "first try" for generating 398
VPs. Furthermore, it is the only method that can be run (at least in part) without 399 prior knowledge of the target distribution. This relaxed requirement can make it an 400 attractive choice for pre-computing plausible populations or for exploring how the 401 parameter space relates to the model output (for example, identifying parameters in 402 the model that can give rise to sub-populations of interest). 403
The NSA approach iterates on the SA method by utilizing prior knowledge of the 404 final parameter distribution and forcing the algorithm to regions with the most 405 desired patient density. This method is likely most efficient when the target 406 distribution is approximately ellipse-shaped. Fortunately, for the example here, the 407 The implications of this for direct convergence of this method will depend on the 435 symmetry of the observable distribution (induced by the parameter sampling) 436 around every point on the Markov chain. In this case, the approximation we 437 assumed (see Methods) appeared to hold sufficiently for the MH algorithm to 438 approximate the empirical distributions. However, the final Vpop was improved by 439 acceptance/rejection sampling. 440
The genetic algorithm was very similar to MH in that, compared to the SA-based 441 methods, a 10-fold improvement in computational speed was achieved at the cost of 442 some lost heterogeneity in the final virtual population. The GA is easy to implement 443 for QSP models and the supplied routine with MATLAB's Global Optimization 444
Toolbox was sufficient for our purposes. GA requires some problem-specific 445 decisions, which may affect overall performance; for example, the size of the 446 population, number of generations, and mutation rate can be adjusted as needed. 447
The curse of under-determined models has led to a long history of using different peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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